{ "responseHeader":{ "status":0, "QTime":0, "params":{ "q":"iati_identifier:GB-COH-03877777-F318901-01", "fl":"*", "format":"json" } }, "response":{ "numFound":1, "start":0, "numFoundExact":true, "docs":[{ "last-updated-datetime":"2025-06-27T07:24:56Z", "last_updated_datetime":"Fri Jun 27 07:24:56 UTC 2025", "last_updated_datetime_f":"2025-06-27T07:24:56Z", "lang":"en", "default_lang":"en", "default-currency":"USD", "default_currency":"USD", "humanitarian":false, "hierarchy":1, "iati-identifier":"GB-COH-03877777-F318901-01", "iati_identifier":"GB-COH-03877777-F318901-01", "reporting-org.type":"15", "reporting_org_type_code":"15", "reporting-org.ref":"GB-COH-03877777", "reporting_org_ref":"GB-COH-03877777", "reporting-org.secondary-reporter":false, "reporting_org_secondary_reporter":"0", "reporting-org.narrative":[" British International Investment plc"], "reporting_org_narrative":[" British International Investment plc"], "reporting-org.narrative.lang":["en"], "title.narrative":["MedAccess"], "title_narrative":["MedAccess"], "title_narrative_text":["MedAccess"], "title.narrative.lang":[" "], "title_narrative_lang":[" "], "description.type":["1","4"], "description_type":["1","4"], "description.narrative":["MedAccess is an innovative social finance company committed to expanding and accelerating access to life-saving medicines, vaccines and diagnostics in Africa and South Asia. The company launched in 2017, with a huge amount of support and input from DFID (which had the initial idea to create the company), the Clinton Health Access Initiative (CHAI) and the Bill and Melinda Gates Foundation (BMGF).","Equity"], "description_narrative":["MedAccess is an innovative social finance company committed to expanding and accelerating access to life-saving medicines, vaccines and diagnostics in Africa and South Asia. The company launched in 2017, with a huge amount of support and input from DFID (which had the initial idea to create the company), the Clinton Health Access Initiative (CHAI) and the Bill and Melinda Gates Foundation (BMGF).","Equity"], "description_narrative_text":["MedAccess is an innovative social finance company committed to expanding and accelerating access to life-saving medicines, vaccines and diagnostics in Africa and South Asia. The company launched in 2017, with a huge amount of support and input from DFID (which had the initial idea to create the company), the Clinton Health Access Initiative (CHAI) and the Bill and Melinda Gates Foundation (BMGF).","Equity"], "description.narrative.lang":[" "," "], "description_narrative_lang":[" "," "], "participating-org.ref":["GB-COH-03877777"], "participating_org_ref":["GB-COH-03877777"], "participating-org.type":["15"], "participating_org_type":["15"], "participating-org.role":["1"], "participating_org_role":["1"], "participating-org.narrative":["British International Investment plc"], "participating_org_narrative":["British International Investment plc"], "participating_org_narrative_text":["British International Investment plc"], "participating-org.narrative.lang":[" "], "participating_org_narrative_lang":[" "], "activity-status.code":"2", "activity_status_code":"2", "activity-date.type":["2","1"], "activity_date_type":["2","1"], "activity-date.iso-date":["2017-12-19T00:00:00Z","2017-12-19T00:00:00Z"], "activity_date_iso_date":["2017-12-19T00:00:00Z","2017-12-19T00:00:00Z"], "contact-info.type":["4"], "contact_info_type":["4"], "contact-info.organisation.narrative":["British International Investment plc"], "contact_info_organisation_narrative":["British International Investment plc"], "contact_info_organisation_narrative_text":["British International Investment plc"], "contact-info.organisation.narrative.lang":[" "], "contact_info_organisation_narrative_lang":[" "], "contact-info.department.narrative":["Communications Department"], "contact_info_department_narrative":["Communications Department"], "contact_info_department_narrative_text":["Communications Department"], "contact-info.department.narrative.lang":[" "], "contact_info_department_narrative_lang":[" "], "contact-info.telephone":["+44 20 7963 4700"], "contact_info_telephone":["+44 20 7963 4700"], "contact-info.email":["enquiries@bii.co.uk"], "contact_info_email":["enquiries@bii.co.uk"], "contact-info.website":["https://www.bii.co.uk"], "contact_info_website":["https://www.bii.co.uk"], "contact-info.mailing-address.narrative":["BII plc, 123 Victoria Street, London, SW1E 6DE, United Kingdom"], "contact_info_mailing_address_narrative":["BII plc, 123 Victoria Street, London, SW1E 6DE, United Kingdom"], "contact_info_mailing_address_narrative_text":["BII plc, 123 Victoria Street, London, SW1E 6DE, United Kingdom"], "contact-info.mailing-address.narrative.lang":[" "], "contact_info_mailing_address_narrative_lang":[" "], "recipient-country.code":["ZM"], "recipient_country_code":["ZM"], "recipient-country.percentage":[100.0], "recipient_country_percentage":[100.0], "sector.code":["352020"], "sector_code":["352020"], "sector.vocabulary":["99"], "sector_vocabulary":["99"], "sector.vocabulary-uri":["https://aidstream.org/reference/codelist/GB-COH-03877777/sector"], "sector_vocabulary_uri":["https://aidstream.org/reference/codelist/GB-COH-03877777/sector"], "sector.narrative":["Pharmaceuticals"], "sector_narrative":["Pharmaceuticals"], "sector_narrative_text":["Pharmaceuticals"], "sector.narrative.lang":[" "], "sector_narrative_lang":[" "], "collaboration-type.code":"6", "collaboration_type_code":"6", "default-flow-type.code":"10", "default_flow_type_code":"10", "default-aid-type.code":["C01"], "default_aid_type":["C01"], "default_aid_type_category_code":["C01"], "default_aid_type_code":["C01"], "default-aid-type.vocabulary":["1"], "default_aid_type_vocabulary":["1"], "default-tied-status.code":"5", "default_tied_status_code":"5", "transaction.transaction-type.code":["2","2","2"], "transaction_type":["2","2","2"], "transaction.transaction-date.iso-date":["2017-12-19T00:00:00Z","2017-12-19T00:00:00Z","2017-12-19T00:00:00Z"], "transaction_date_iso_date":["2017-12-19T00:00:00Z","2017-12-19T00:00:00Z","2017-12-19T00:00:00Z"], "transaction.value":[2.0E8,2.0E8,2.0E8], "transaction_value":[2.0E8,2.0E8,2.0E8], "transaction.description.narrative":["CFAM has been established as a wholly owned subsidiary of CDC with an initial capital commitment of $200 million, with a further potential funding opportunity of $300 million. We will be looking to raise additional capital from third-party investors in the future.","CFAM has been established as a wholly owned subsidiary of CDC with an initial capital commitment of $200 million, with a further potential funding opportunity of $300 million. We will be looking to raise additional capital from third-party investors in the future.","CFAM has been established as a wholly owned subsidiary of CDC with an initial capital commitment of $200 million, with a further potential funding opportunity of $300 million. We will be looking to raise additional capital from third-party investors in the future."], "transaction_description_narrative":["CFAM has been established as a wholly owned subsidiary of CDC with an initial capital commitment of $200 million, with a further potential funding opportunity of $300 million. We will be looking to raise additional capital from third-party investors in the future.","CFAM has been established as a wholly owned subsidiary of CDC with an initial capital commitment of $200 million, with a further potential funding opportunity of $300 million. We will be looking to raise additional capital from third-party investors in the future.","CFAM has been established as a wholly owned subsidiary of CDC with an initial capital commitment of $200 million, with a further potential funding opportunity of $300 million. We will be looking to raise additional capital from third-party investors in the future."], "transaction.description.narrative.lang":[" "," "," "], "transaction_description_lang":[" "," "," "], "transaction.provider-org.ref":["GB-COH-03877777","GB-COH-03877777","GB-COH-03877777"], "transaction_provider_org_ref":["GB-COH-03877777","GB-COH-03877777","GB-COH-03877777"], "transaction.provider-org.provider-activity-id":["GB-COH-03877777","GB-COH-03877777","GB-COH-03877777"], "transaction_provider_org_provider_activity_id":["GB-COH-03877777","GB-COH-03877777","GB-COH-03877777"], "transaction.provider-org.type":["70","70","70"], "transaction_provider_org_type":["70","70","70"], "transaction.provider-org.narrative":["British International Investment plc","British International Investment plc","British International Investment plc"], "transaction_provider_org_narrative":["British International Investment plc","British International Investment plc","British International Investment plc"], "transaction_provider_org_narrative_text":["British International Investment plc","British International Investment plc","British International Investment plc"], "transaction.provider-org.narrative.lang":[" "," "," "], "transaction_provider_org_narrative_lang":[" "," "," "], "transaction.receiver-org.narrative":["https://medaccess.org/","https://medaccess.org/","https://medaccess.org/"], "transaction_receiver_org_narrative":["https://medaccess.org/","https://medaccess.org/","https://medaccess.org/"], "transaction_receiver_org_narrative_text":["https://medaccess.org/","https://medaccess.org/","https://medaccess.org/"], "transaction.receiver-org.narrative.lang":[" "," "," "], "transaction_receiver_org_narrative_lang":[" "," "," "], "transaction.value.value-date":["2017-12-19T00:00:00Z","2017-12-19T00:00:00Z","2017-12-19T00:00:00Z"], "transaction_value_date":["2017-12-19T00:00:00Z","2017-12-19T00:00:00Z","2017-12-19T00:00:00Z"], "document-link.url":["https://www.bii.co.uk/en/our-impact/investment/medaccess-investment-01/"], "document_link_url":["https://www.bii.co.uk/en/our-impact/investment/medaccess-investment-01/"], "document-link.format":["application/link-format"], "document_link_format":["application/link-format"], "document-link.title.narrative":["Quartely Report"], "document_link_title_narrative":["Quartely Report"], "document_link_title_narrative_text":["Quartely Report"], "document-link.title.narrative.lang":[" "], "document_link_title_narrative_lang":[" "], "document-link.category.code":["A12"], "document_link_category_code":["A12"], "document-link.language.code":["en"], "document_link_language_code":["en"], "document-link.document-date.iso-date":["2025-07-01T00:00:00Z"], "document_link_document_date_iso_date":["2025-07-01T00:00:00Z"], "reporting-org.type.name":"Other Public Sector", "reporting_org_type_name":"Other Public Sector", "recipient-country.name":["Zambia"], "recipient_country_name":["Zambia"], "default-aid-type.name":["Project-type interventions"], "default_aid_type_category_name":["Project-type interventions"], "title.narrative.first":"MedAccess", "title_narrative_first":"MedAccess", "activity-date.start-actual":"2017-12-19T00:00:00Z", "activity_date_start_actual":"Tue Dec 19 00:00:00 UTC 2017", "activity_date_start_actual_f":"2017-12-19T00:00:00Z", "activity-date.common.start":"2017-12-19T00:00:00Z", "activity_date_start_common":"Tue Dec 19 00:00:00 UTC 2017", "activity_date_start_common_f":"2017-12-19T00:00:00Z", "activity-date.start-planned":"2017-12-19T00:00:00Z", "activity_date_start_planned":"Tue Dec 19 00:00:00 UTC 2017", "activity_date_start_planned_f":"2017-12-19T00:00:00Z", "activity-status.text":"Implementation", "activity_status_text":"Implementation", "transaction.value-usd.sum":6.0E8, "transaction_value_usd_sum":6.0E8, "transaction.value-usd.conversion-rate":[1.0,1.0,1.0], "transaction_usd_conversion_rate":[1.0,1.0,1.0], "transaction.value-usd.conversion-currency":["USD"], "transaction.value-gbp.sum":4.476193155763555E8, "transaction_value_gbp_sum":4.476193155763555E8, "transaction.value-gbp.conversion-rate":[1.3404247294990808,1.3404247294990808,1.3404247294990808], "transaction_gbp_conversion_rate":[1.3404247294990808,1.3404247294990808,1.3404247294990808], "transaction.value-gbp.conversion-currency":["USD"], "dataset.id":"7e4b5f6f-a12c-4a85-b555-e63f75af07b5", "dataset_iati_id":"7e4b5f6f-a12c-4a85-b555-e63f75af07b5", "dataset.name":"bii-activities", "dataset_name":"bii-activities", "dataset.extras.iati_version":"2.03", "dataset.resources.hash":"45892ebb68e2a1f3ed94b9d52c4bb262558a46e3", "dataset.resources.url":"https://aidstream.s3.us-west-2.amazonaws.com/xml/bii-activities.xml", "activity-date.quarter":[4,4], "transaction.transaction-date.quarter":[4,4,4], "document-link.document-date.quarter":[3], "document-link.category-codes-combined":["A12"], "transaction.value-usd":[2.0E8,2.0E8,2.0E8], "transaction_value_usd":[2.0E8,2.0E8,2.0E8], "transaction.value-usd-type":[2,2,2], "transaction.value-gbp":[1.4920643852545184E8,1.4920643852545184E8,1.4920643852545184E8], "transaction_value_gbp":[1.4920643852545184E8,1.4920643852545184E8,1.4920643852545184E8], "transaction.value-gbp-type":[2,2,2], "activity-aggregation.outgoing-commitment.value":6.0E8, "activity_aggregation_commitment_value":6.0E8, "activity-aggregation.outgoing-commitment.value-usd":6.0E8, "activity_aggregation_commitment_value_usd":6.0E8, "activity-aggregation.outgoing-commitment.value-gbp":4.476193155763555E8, "activity_aggregation_commitment_value_gbp":4.476193155763555E8, "json.reporting-org":"{\"type\": 15, \"ref\": \"GB-COH-03877777\", \"secondary-reporter\": 0, \"narrative\": \" British International Investment plc\", \"narrative.lang\": \"en\"}", "json.title":"{\"narrative\": \"MedAccess\", \"narrative.lang\": \" \"}", "json.description":["{\"type\": 1, \"narrative\": \"MedAccess is an innovative social finance company committed to expanding and accelerating access to life-saving medicines, vaccines and diagnostics in Africa and South Asia. The company launched in 2017, with a huge amount of support and input from DFID (which had the initial idea to create the company), the Clinton Health Access Initiative (CHAI) and the Bill and Melinda Gates Foundation (BMGF).\", \"narrative.lang\": \" \"}","{\"type\": 4, \"narrative\": \"Equity\", \"narrative.lang\": \" \"}"], "json.participating-org":["{\"ref\": \"GB-COH-03877777\", \"type\": 15, \"role\": 1, \"narrative\": \"British International Investment plc\", \"narrative.lang\": \" \"}"], "json.activity-date":["{\"type\": 2, \"iso-date\": \"2017-12-19\"}","{\"type\": 1, \"iso-date\": \"2017-12-19\"}"], "json.contact-info":["{\"type\": 4, \"organisation\": {\"narrative\": \"British International Investment plc\", \"narrative.lang\": \" \"}, \"department\": {\"narrative\": \"Communications Department\", \"narrative.lang\": \" \"}, \"telephone\": \"+44 20 7963 4700\", \"email\": \"enquiries@bii.co.uk\", \"website\": \"https://www.bii.co.uk\", \"mailing-address\": {\"narrative\": \"BII plc, 123 Victoria Street, London, SW1E 6DE, United Kingdom\", \"narrative.lang\": \" \"}}"], "json.recipient-country":["{\"code\": \"ZM\", \"percentage\": 100}"], "json.sector":["{\"code\": 352020, \"vocabulary\": 99, \"vocabulary-uri\": \"https://aidstream.org/reference/codelist/GB-COH-03877777/sector\", \"narrative\": \"Pharmaceuticals\", \"narrative.lang\": \" \"}"], "json.default-aid-type":["{\"code\": \"C01\", \"vocabulary\": 1}"], "json.transaction":["{\"transaction-type\": {\"code\": 2}, \"transaction-date\": {\"iso-date\": \"2017-12-19\"}, \"value\": 200000000, \"description\": {\"narrative\": \"CFAM has been established as a wholly owned subsidiary of CDC with an initial capital commitment of $200 million, with a further potential funding opportunity of $300 million. We will be looking to raise additional capital from third-party investors in the future.\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"GB-COH-03877777\", \"provider-activity-id\": \"GB-COH-03877777\", \"type\": 70, \"narrative\": \"British International Investment plc\", \"narrative.lang\": \" \"}, \"receiver-org\": {\"narrative\": \"https://medaccess.org/\", \"narrative.lang\": \" \"}, \"value.value-date\": \"2017-12-19\"}","{\"transaction-type\": {\"code\": 2}, \"transaction-date\": {\"iso-date\": \"2017-12-19\"}, \"value\": 200000000, \"description\": {\"narrative\": \"CFAM has been established as a wholly owned subsidiary of CDC with an initial capital commitment of $200 million, with a further potential funding opportunity of $300 million. We will be looking to raise additional capital from third-party investors in the future.\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"GB-COH-03877777\", \"provider-activity-id\": \"GB-COH-03877777\", \"type\": 70, \"narrative\": \"British International Investment plc\", \"narrative.lang\": \" \"}, \"receiver-org\": {\"narrative\": \"https://medaccess.org/\", \"narrative.lang\": \" \"}, \"value.value-date\": \"2017-12-19\"}","{\"transaction-type\": {\"code\": 2}, \"transaction-date\": {\"iso-date\": \"2017-12-19\"}, \"value\": 200000000, \"description\": {\"narrative\": \"CFAM has been established as a wholly owned subsidiary of CDC with an initial capital commitment of $200 million, with a further potential funding opportunity of $300 million. We will be looking to raise additional capital from third-party investors in the future.\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"GB-COH-03877777\", \"provider-activity-id\": \"GB-COH-03877777\", \"type\": 70, \"narrative\": \"British International Investment plc\", \"narrative.lang\": \" \"}, \"receiver-org\": {\"narrative\": \"https://medaccess.org/\", \"narrative.lang\": \" \"}, \"value.value-date\": \"2017-12-19\"}"], "json.document-link":["{\"url\": \"https://www.bii.co.uk/en/our-impact/investment/medaccess-investment-01/\", \"format\": \"application/link-format\", \"title\": {\"narrative\": \"Quartely Report\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A12\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2025-07-01\"}]}"], "id":"2481098d-e956-413f-a230-6600b6c16641", "_version_":1863489638700679168 }] } }